In a time of increasingly personalized healthcare, Elizabeth Philp has become a leading force of innovation, particularly in the technologically advancing field of compounded pharmacy. As the chief executive and co-founder of Roseway Labs, Philp is at the helm of a movement to make bespoke medications more accessible, questioning the standard one-